Search results
NHS medicines information on alendronic acid – what it's used for, side effects, dosage and who can take it.
Alendronate*, risedronate*, zoledronic acid, denosumab and teriparatide† are licensed for the treatment of osteoporosis in men. Alendronate and risedronate should be the first line treatments in the majority of cases. *Only alendronate 10mg daily tablet and risedronate 35mg weekly tablet are licensed for use in men.
9 sie 2017 · Alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid are bisphosphonates, licensed for treating osteoporosis. Currently clinicians offer bisphosphonates to people with osteoporosis who are eligible for risk assessment and who have a high fracture risk.
Recommendations. Review whether the bisphosphonate can be stopped, either completely or for a treatment break, at the following intervals: . Three years for patients with multimorbidity (two or more long-term conditions) . Five years for alendronic acid, risedronate sodium, and ibandronic acid for all patients.
9 sie 2017 · Overview. Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis. NICE has produced a patient decision aid on bisphosphonates for treating osteoporosis to support discussions. Last reviewed: 8 July 2019.
6 sie 2023 · You may be prescribed alendronic acid to take once a day (10 mg strength tablets), or more commonly, once a week (70 mg strength tablets/medicine). In the brands of tablets called Fosavance® and Bentexo®, alendronic acid is combined with a vitamin called colecalciferol (also known as vitamin D3).
Alendronate (Alendronic acid, Fosamax or Binosto) This leaflet explains about alendronate treatment for osteoporosis, including how it works, how to take it and any risks and benefits.
